rs10858282

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):c.4176+9T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 1,609,628 control chromosomes in the GnomAD database, including 111,610 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8236 hom., cov: 33)

Exomes 𝑓: 0.37 ( 103374 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.823

Variant links:

Genes affected

COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]

COL5A1 links:

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.85).

BP6

Variant 9-134817088-T-G is Benign according to our data. Variant chr9-134817088-T-G is described in ClinVar as [Benign]. Clinvar id is 136891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-134817088-T-G is described in Lovd as [Benign].

BA1

GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	Effect	MANE
COL5A1	NM_000093.5 linkuse as main transcript	c.4176+9T>G	intron_variant	ENST00000371817.8
COL5A1	NM_001278074.1 linkuse as main transcript	c.4176+9T>G	intron_variant
COL5A1	XM_017014266.3 linkuse as main transcript	c.4176+9T>G	intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
COL5A1	ENST00000371817.8 linkuse as main transcript	c.4176+9T>G		intron_variant		1	NM_000093.5	P4	P20908-1
COL5A1	ENST00000371820.4 linkuse as main transcript	c.4176+9T>G		intron_variant		2		A2	P20908-2

Frequencies

GnomAD3 genomes

AF:

0.317

AC:

48186

AN:

151964

Hom.:

8235

Cov.:

show subpopulations

Gnomad AFR

AF:

0.191

Gnomad AMI

AF:

0.393

Gnomad AMR

AF:

0.303

Gnomad ASJ

AF:

0.330

Gnomad EAS

AF:

0.328

Gnomad SAS

AF:

0.286

Gnomad FIN

AF:

0.342

Gnomad MID

AF:

0.370

Gnomad NFE

AF:

0.392

Gnomad OTH

AF:

0.327

GnomAD3 exomes

AF:

0.343

AC:

86015

AN:

251026

Hom.:

15246

AF XY:

0.345

AC XY:

46816

AN XY:

135728

show subpopulations

Gnomad AFR exome

AF:

0.182

Gnomad AMR exome

AF:

0.302

Gnomad ASJ exome

AF:

0.336

Gnomad EAS exome

AF:

0.342

Gnomad SAS exome

AF:

0.305

Gnomad FIN exome

AF:

0.337

Gnomad NFE exome

AF:

0.389

Gnomad OTH exome

AF:

0.358

GnomAD4 exome

AF:

0.373

AC:

543233

AN:

1457548

Hom.:

103374

Cov.:

AF XY:

0.372

AC XY:

269826

AN XY:

725302

show subpopulations

Gnomad4 AFR exome

AF:

0.186

Gnomad4 AMR exome

AF:

0.302

Gnomad4 ASJ exome

AF:

0.331

Gnomad4 EAS exome

AF:

0.318

Gnomad4 SAS exome

AF:

0.305

Gnomad4 FIN exome

AF:

0.339

Gnomad4 NFE exome

AF:

0.392

Gnomad4 OTH exome

AF:

0.356

GnomAD4 genome

AF:

0.317

AC:

48202

AN:

152080

Hom.:

8236

Cov.:

AF XY:

0.313

AC XY:

23259

AN XY:

74342

show subpopulations

Gnomad4 AFR

AF:

0.191

Gnomad4 AMR

AF:

0.303

Gnomad4 ASJ

AF:

0.330

Gnomad4 EAS

AF:

0.328

Gnomad4 SAS

AF:

0.286

Gnomad4 FIN

AF:

0.342

Gnomad4 NFE

AF:

0.393

Gnomad4 OTH

AF:

0.327

Alfa

AF:

0.357

Hom.:

5620

Bravo

AF:

0.311

Asia WGS

AF:

0.288

AC:

1005

AN:

3478

ClinVar

Significance: Benign

Submissions summary: Benign:10

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not specified

Benign:5

Benign, criteria provided, single submitter	clinical testing	PreventionGenetics, part of Exact Sciences	-	- -
Benign, criteria provided, single submitter	clinical testing	GeneDx	Nov 02, 2012	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria provided	clinical testing	Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	-	- -
Benign, no assertion criteria provided	clinical testing	Genome Diagnostics Laboratory, Amsterdam University Medical Center	-	- -
Benign, no assertion criteria provided	clinical testing	Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen	-	- -

Ehlers-Danlos syndrome, classic type, 1

Benign:2

Benign, criteria provided, single submitter	clinical testing	Genome-Nilou Lab	Jul 30, 2021	- -
Benign, criteria provided, single submitter	clinical testing	Invitae	Feb 01, 2024	- -

Fibromuscular dysplasia, multifocal

Benign:1

Benign, criteria provided, single submitter

clinical testing

Genome-Nilou Lab

Jul 30, 2021

- -

Ehlers-Danlos syndrome type 7A

Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jun 14, 2016

- -

not provided

Benign:1

Benign, criteria provided, single submitter

clinical testing

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Mar 10, 2017

Variant summary: The COL5A1 c.4176+9T>G variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 4/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 41350/120980 control chromosomes (7355 homozygotes) at a frequency of 0.341792, which is approximately 273433 times the estimated maximal expected allele frequency of a pathogenic COL5A1 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.85

Cadd

Benign

0.041

Dann

Benign

0.36

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

LitVar

Other links and lift over